BurrowsGDKremerCME. Mirtazapine: Clinical advantages in the treatment of depression. J Clin Psychpharmacol1997;17 (Suppl 1):34S–39S.
2.
RooseSP. Tolerability and patient compliance. J Clin Psychiatry1990;60 (Suppl 17):14–7.
3.
StahlSZivkovMReimitzPEPanagidesJHoffJW. Meta-analysis of randomized, double blind, placebo controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression. Acta Psychiatr Scand Suppl1997;391:22–30.
4.
FawcettJBarklinRL. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord1998;51:267–85.
5.
GoodnickPJPuigADevaneCLFreundBV. Mirtazapine in major depression with comorbid general anxiety disorder. J Clin Psychiatry1999;60:446–8.
6.
PuzantinT.Mirtazapine, an antidepressant. Am J Health Syst Pharm1998;55:44–9.